Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups.

Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH, Gillenwater HH, Watson DM, Sugarbaker DJ, Schilsky RL, Vokes EE, Green MR.

J Clin Oncol. 2008 Nov 1;26(31):5043-51. doi: 10.1200/JCO.2008.16.4855. Epub 2008 Sep 22.

2.

The present status of postoperative adjuvant chemotherapy for completely resected non-small cell lung cancer.

Tsuboi M, Ohira T, Saji H, Miyajima K, Kajiwara N, Uchida O, Usuda J, Kato H.

Ann Thorac Cardiovasc Surg. 2007 Apr;13(2):73-7. Review.

PMID:
17505412
3.

Patient subsets benefiting from adjuvant therapy following surgical resection of non-small cell lung cancer.

Johnson BE, Rabin MS.

Clin Cancer Res. 2005 Jul 1;11(13 Pt 2):5022s-5026s. Review.

4.

Adjuvant chemotherapy for surgically resected non-small cell lung cancer.

Heon S, Johnson BE.

J Thorac Cardiovasc Surg. 2012 Sep;144(3):S39-42. doi: 10.1016/j.jtcvs.2012.03.039. Epub 2012 Apr 13. Review.

5.

Impact of adjuvant chemotherapy in completely resected stage IIIA non-small cell lung cancer.

Naim Younes R, Gross JL, Abrao FG, Rodrigues Pereira J.

Minerva Chir. 2013 Apr;68(2):169-74. Review.

PMID:
23612230
6.

Platinum-based adjuvant chemotherapy on moderate- and high-risk stage I and II epithelian ovarian cancer patients. Long-term single institution experience and literature review.

García-Sáenz JA, Custodio A, Casado A, Vidart JA, Coronado PJ, Martín M, López-Tarruella S, Puente J, Fernández C, Díaz-Rubio E.

Clin Transl Oncol. 2011 Feb;13(2):121-32. doi: 10.1007/s12094-011-0629-6. Review.

PMID:
21324801
7.

Postoperative adjuvant therapy for completely resected early-stage non-small cell lung cancer.

Kato H, Tsuboi M, Kato Y, Ikeda N, Okunaka T, Hamada C.

Int J Clin Oncol. 2005 Jun;10(3):157-64. Review.

PMID:
15990962
8.

Adjuvant chemotherapy in older adults with non-small cell lung cancer.

Gajra A.

Am Soc Clin Oncol Educ Book. 2013. doi: 10.1200/EdBook_AM.2013.33.e185. Review.

9.

Adjuvant chemotherapy for completely resected non-small-cell lung cancer.

Suehisa H, Toyooka S.

Acta Med Okayama. 2009 Oct;63(5):223-30. Review.

10.

Adjuvant Chemotherapy for the Completely Resected Stage IB Nonsmall Cell Lung Cancer: A Systematic Review and Meta-Analysis.

He J, Shen J, Yang C, Jiang L, Liang W, Shi X, Xu X, He J.

Medicine (Baltimore). 2015 Jun;94(22):e903. doi: 10.1097/MD.0000000000000903. Review.

11.

Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review.

Gilligan D, Nicolson M, Smith I, Groen H, Dalesio O, Goldstraw P, Hatton M, Hopwood P, Manegold C, Schramel F, Smit H, van Meerbeeck J, Nankivell M, Parmar M, Pugh C, Stephens R.

Lancet. 2007 Jun 9;369(9577):1929-37. Review.

PMID:
17544497
12.

Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data.

NSCLC Meta-analysis Collaborative Group.

Lancet. 2014 May 3;383(9928):1561-71. doi: 10.1016/S0140-6736(13)62159-5. Epub 2014 Feb 25. Review.

13.

Individualized adjuvant chemotherapy for surgically resected lung cancer and the roles of biomarkers.

Ikeda N, Nagase S, Ohira T.

Ann Thorac Cardiovasc Surg. 2009 Jun;15(3):144-9. Review.

PMID:
19597387
14.

Locally Advanced Non-Small Cell Lung Cancer: Optimal Chemotherapeutic Agents and Duration.

Mamdani H, Jalal SI, Hanna N.

Curr Treat Options Oncol. 2015 Oct;16(10):47. doi: 10.1007/s11864-015-0364-2. Review.

PMID:
26233240
15.

Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.

Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP.

J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. Review.

PMID:
20351327
16.

Adjuvant chemotherapy for resected non-small-cell lung cancer: future perspectives for clinical research.

Bonomi M, Pilotto S, Milella M, Massari F, Cingarlini S, Brunelli M, Chilosi M, Tortora G, Bria E.

J Exp Clin Cancer Res. 2011 Dec 29;30:115. doi: 10.1186/1756-9966-30-115. Review.

17.

[Neo-adjuvant chemotherapy of non-small cell bronchial cancers (NSCLC)].

Milleron B, Westeel V, Depierre A.

Presse Med. 2002 May 11;31(17):797-801. Review. French.

PMID:
12148364
18.
19.

Adjuvant Therapy of Resected Non-small Cell Lung Cancer: can We Move Forward?

Buffoni L, Vavalà T, Novello S.

Curr Treat Options Oncol. 2016 Oct;17(10):54. doi: 10.1007/s11864-016-0429-x. Review.

PMID:
27523606
20.

Role of Chemotherapy and Targeted Therapy in Early-Stage Non-Small Cell Lung Cancer.

Gadgeel SM.

Am Soc Clin Oncol Educ Book. 2017;37:630-639. doi: 10.14694/EDBK_175188. Review.

Supplemental Content

Support Center